Cephalexin is not considered a strong antibiotic in the broad sense, but it is highly effective against the specific bacteria it targets. It belongs to the first generation of cephalosporin antibiotics, which means it has a narrower range of coverage compared to newer, broader-spectrum options. That narrower focus is actually a feature, not a flaw: for common skin infections, strep throat, ear infections, and urinary tract infections, cephalexin often works just as well as or better than broader antibiotics.
The real answer to “is it strong?” depends on what infection you’re treating. Against the right bacteria, cephalexin is potent and reliable. Against the wrong ones, it won’t work at all.
What Cephalexin Is Designed to Kill
Cephalexin works best against gram-positive bacteria, the family of organisms responsible for most skin infections, strep throat, and many ear infections. Its primary targets include Staphylococcus aureus (the staph behind wound infections, cellulitis, and abscesses), Streptococcus pyogenes (the bacterium behind strep throat and impetigo), and Streptococcus pneumoniae (a common cause of ear infections and some respiratory infections). It can also handle penicillinase-producing strains of staph, meaning bacteria that have developed a defense against basic penicillin are still vulnerable to cephalexin.
It has some activity against a handful of gram-negative bacteria as well. It covers E. coli, Proteus mirabilis, and Klebsiella pneumoniae, which are common causes of urinary tract infections. But its gram-negative coverage is limited compared to later-generation antibiotics.
Where Cephalexin Falls Short
The most important gap in cephalexin’s coverage is MRSA, or methicillin-resistant Staphylococcus aureus. MRSA bacteria carry a genetic change that alters the protein cephalexin needs to bind to in order to kill the cell. This makes MRSA resistant to nearly all cephalosporins, not just cephalexin. If your doctor suspects MRSA (common in recurring skin abscesses or infections acquired in hospitals), cephalexin is the wrong choice, and a different class of antibiotic is needed.
Cephalexin also doesn’t work against most enterococci, a group of bacteria that can cause urinary tract and abdominal infections. And penicillin-resistant strains of Streptococcus pneumoniae tend to be cross-resistant to cephalexin as well. So while cephalexin handles many everyday infections, it has clear blind spots with resistant organisms.
How It Compares to Other Antibiotics
Cephalexin is a first-generation cephalosporin. The “generation” system is often what people are really asking about when they wonder if an antibiotic is strong. Each successive generation of cephalosporins covers a wider range of gram-negative bacteria, but typically at the cost of some gram-positive activity. Third-generation cephalosporins, for example, can handle more complex gram-negative infections but are actually slightly weaker against gram-positive bacteria like staph and strep.
For skin and soft tissue infections specifically, first-generation cephalosporins like cephalexin perform as well as or better than third-generation cephalosporins. A meta-analysis reviewed by the American Academy of Family Physicians found that while fluoroquinolones (a completely different antibiotic class) had a slightly higher overall success rate for skin infections than beta-lactam antibiotics (90.4% versus 88.2%), that difference disappeared when third-generation cephalosporins were removed from the comparison. In other words, the “newer” cephalosporins were dragging down the average, and first-generation drugs like cephalexin were holding their own.
Compared to amoxicillin, another common oral antibiotic, cephalexin covers similar territory but adds better staph coverage. This is why cephalexin is frequently the go-to for skin infections, while amoxicillin is more commonly chosen for sinus infections and dental infections.
FDA-Approved Uses
Cephalexin is FDA-approved for five categories of infection:
- Skin and soft tissue infections caused by staph and strep, including cellulitis, wound infections, and impetigo
- Respiratory tract infections caused by Streptococcus pneumoniae and Streptococcus pyogenes
- Ear infections (otitis media) caused by several bacteria including staph, strep, and Haemophilus influenzae
- Urinary tract infections caused by E. coli, Proteus mirabilis, and Klebsiella pneumoniae, including acute prostatitis
- Bone infections caused by staph and Proteus mirabilis
That bone infection approval is worth noting. Oral antibiotics used for bone infections need to reach adequate concentrations in tissue over a sustained period. The fact that cephalexin is approved for this use speaks to its ability to maintain effective drug levels when dosed appropriately.
How Quickly It Works
Cephalexin is absorbed relatively fast after you take it by mouth. Blood levels peak around 1.3 hours after a dose, and the drug has a half-life of roughly one hour in people with normal kidney function. That short half-life is why it’s typically prescribed to be taken every 6 to 12 hours, keeping a steady level of the drug in your system throughout the day. The standard adult dose ranges from 1,000 to 4,000 milligrams per day, split into multiple doses.
Most people notice improvement within 2 to 3 days of starting treatment, though the full course (usually 7 to 14 days depending on the infection) needs to be completed even after symptoms improve. Stopping early increases the risk of the infection coming back and potentially becoming resistant.
Why “Strong” Is the Wrong Question
Antibiotics aren’t ranked on a simple weak-to-strong scale. A narrow-spectrum antibiotic that precisely targets the bacteria causing your infection is more effective for you than a broad-spectrum antibiotic that covers dozens of bacteria you don’t have. Cephalexin’s strength is its reliability against the gram-positive organisms behind most skin infections, strep throat, and uncomplicated UTIs, paired with the convenience of being taken by mouth rather than through an IV.
Broader antibiotics come with trade-offs. They’re more likely to disrupt your gut bacteria, more likely to cause secondary infections like C. difficile colitis, and more likely to contribute to antibiotic resistance in the community. When cephalexin is the right fit for an infection, choosing it over a broader drug is better medicine, not weaker medicine.
Where cephalexin genuinely isn’t strong enough is against resistant organisms like MRSA, against many hospital-acquired infections, and against bacteria that live in hard-to-reach places like the central nervous system (cephalexin doesn’t penetrate the blood-brain barrier well). For those situations, different antibiotics with different properties are necessary. But for the everyday infections it’s designed to treat, cephalexin is a proven, effective choice that has remained a clinical workhorse for decades.